Format

Send to:

Choose Destination

Related Articles by Review for PubMed (Select 23434592)

See comment in PubMed Commons below
J Clin Invest. 2013 Mar;123(3):1082-95. doi: 10.1172/JCI64044. Epub 2013 Feb 22.

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Author information

  • 1Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Abstract

Angiopoietin-like protein 1 (ANGPTL1) is a potent regulator of angiogenesis. Growing evidence suggests that ANGPTL family proteins not only target endothelial cells but also affect tumor cell behavior. In a screen of 102 patients with lung cancer, we found that ANGPTL1 expression was inversely correlated with invasion, lymph node metastasis, and poor clinical outcomes. ANGPTL1 suppressed the migratory, invasive, and metastatic capabilities of lung and breast cancer cell lines in vitro and reduced metastasis in mice injected with cancer cell lines overexpressing ANGPTL1. Ectopic expression of ANGPTL1 suppressed the epithelial-to-mesenchymal transition (EMT) by reducing the expression of the zinc-finger protein SLUG. A microRNA screen revealed that ANGPTL1 suppressed SLUG by inducing expression of miR-630 in an integrin α(1)β(1)/FAK/ERK/SP1 pathway-dependent manner. These results demonstrate that ANGPTL1 represses lung cancer cell motility by abrogating the expression of the EMT mediator SLUG.

PMID:
23434592
[PubMed - indexed for MEDLINE]
PMCID:
PMC3582121
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Journal of Clinical Investigation Icon for PubMed Central
    Loading ...
    Write to the Help Desk